COYA vs GENK โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
COYA Captures Institutional Edge (2โ1 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Coya Therapeutics, Inc. Common Stock (COYA) driven by superior Momentum & Technical, Options & Structure while GENK counters with relative strength in Growth & Margin. Fundamentally, COYA trades at N/M Forward P/E with -636.8% operating margin (-93.4% YoY revenue) versus GENK at N/M Forward P/E and -11.3% operating margin (-3.3% YoY). In options structure, COYA sits in BREAKDOWN (46th %ile IV; Dealer Gamma Walls on Pro) against GENK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | COYA | GENK | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $69.9M | $34.4M | Larger Scale | COYA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -93.4% | -3.3% | Higher Growth | GENK |
| Operating Margin (TTM) Profitability | -636.8% | -11.3% | Higher Margin | GENK |
| Net Profit Margin Profitability | 0.0% | -2.3% | Higher Margin | COYA |
| Return on Equity (ROE) Capital Efficiency | -99.2% | -117.1% | Higher ROE | COYA |
| 52-Week Range Position Momentum | 6% ($3โ$7) | 0% ($1โ$3) | Stronger Trend | COYA |
| Beta / 30D Volatility Risk Regime | 1.96ฮฒ ยท 81% Vol | 0.91ฮฒ ยท 132% Vol | Lower Realized Risk | COYA |
| Unified Institutional Score Composite Signal | 64.4 / 100 (BUY) | 47.6 / 100 (HOLD) | Higher Composite | COYA |